Citadel Advisors’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-570,588
| Closed | -$8.68M | – | 6999 |
|
|
2025
Q1 | $8.68M | Sell |
570,588
-77,530
| -12% | -$1.18M | ﹤0.01% | 1342 |
|
|
2024
Q4 | $13.1M | Buy |
648,118
+209,126
| +48% | +$4.24M | ﹤0.01% | 1161 |
|
|
2024
Q3 | $11.3M | Sell |
438,992
-47,976
| -10% | -$1.23M | ﹤0.01% | 1174 |
|
|
2024
Q2 | $6.26M | Buy |
486,968
+332,108
| +214% | +$4.27M | ﹤0.01% | 1512 |
|
|
2024
Q1 | $3.55M | Buy |
+154,860
| New | +$3.55M | ﹤0.01% | 2032 |
|
|
2023
Q4 | – | Sell |
-11,448
| Closed | -$322K | – | 6683 |
|
|
2023
Q3 | $322K | Sell |
11,448
-9,927
| -46% | -$279K | ﹤0.01% | 4198 |
|
|
2023
Q2 | $650K | Sell |
21,375
-83,138
| -80% | -$2.53M | ﹤0.01% | 3389 |
|
|
2023
Q1 | $1.96M | Sell |
104,513
-247,701
| -70% | -$4.66M | ﹤0.01% | 2555 |
|
|
2022
Q4 | $3.59M | Buy |
352,214
+85,957
| +32% | +$877K | ﹤0.01% | 2089 |
|
|
2022
Q3 | $7M | Sell |
266,257
-990
| -0.4% | -$26K | ﹤0.01% | 1565 |
|
|
2022
Q2 | $12.1M | Buy |
267,247
+888
| +0.3% | +$40K | ﹤0.01% | 1147 |
|
|
2022
Q1 | $26.2M | Buy |
266,359
+195
| +0.1% | +$19.2K | 0.01% | 747 |
|
|
2021
Q4 | $40.7M | Sell |
266,164
-783
| -0.3% | -$120K | 0.01% | 571 |
|
|
2021
Q3 | $35.4M | Sell |
266,947
-86
| -0% | -$11.4K | 0.01% | 599 |
|
|
2021
Q2 | $38.1M | Buy |
+267,033
| New | +$38.1M | 0.01% | 614 |
|